Display options
Cite
Isokpehi RD, Cohly HH, Anyanwu MN, et al. Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets. Bioinform Biol Insights. 2010;4:99-111doi: 10.4137/BBI.S5498.
Isokpehi, R. D., Cohly, H. H., Anyanwu, M. N., Rajnarayanan, R. V., Tchounwou, P. B., Udensi, U. K., & Graham-Evans, B. E. (2010). Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets. Bioinformatics and biology insights, 499-111. https://doi.org/10.4137/BBI.S5498
Isokpehi, Raphael D, et al. "Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets." Bioinformatics and biology insights vol. 4 (2010): 99-111. doi: https://doi.org/10.4137/BBI.S5498
Isokpehi RD, Cohly HH, Anyanwu MN, Rajnarayanan RV, Tchounwou PB, Udensi UK, Graham-Evans BE. Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets. Bioinform Biol Insights. 2010 Oct 11;4:99-111. doi: 10.4137/BBI.S5498. PMID: 20981267; PMCID: PMC2964045.
Copy Download .nbib Format: NLM
Share it on

Bioinform Biol Insights. 2010 Oct 11;4:99-111. doi: 10.4137/BBI.S5498.

Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets.

Bioinformatics and biology insights

Raphael D Isokpehi, Hari H P Cohly, Matthew N Anyanwu, Rajendram V Rajnarayanan, Paul B Tchounwou, Udensi K Udensi, Barbara E Graham-Evans

Affiliations

  1. RCMI-Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, Jackson, Mississippi 39217, USA.

PMID: 20981267 PMCID: PMC2964045 DOI: 10.4137/BBI.S5498

Abstract

Arsenic is a toxic metalloid that causes skin cancer and binds to cysteine residues-a property that could be used to infer arsenic responsiveness of a target protein. Non-synonymous Single Nucleotide Polymorphisms (nsSNPs) result in amino acid substitutions and may alter arsenic binding with cysteine residues. Thus, the objective of this investigation was to identify and analyze nsSNPs that lead to substitutions to or from cysteine residues as an indication of increased or decreased arsenic responsiveness. We hypothesize that integration of data on molecular impacts of nsSNPs and arsenic-gene relationships will identify nsSNPs that could serve as arsenic responsiveness markers. We have analyzed functional and structural impacts data for 5,811 nsSNPs linked to 1,224 arsenic-annotated genes. In addition to the identified candidate nsSNPs for increased or reduced arsenic responsiveness, we observed i) a nsSNP that results in the breakage of a disulfide bond, as candidate marker for reduced arsenic responsiveness of KLK7, a secreted serine protease participate in normal shedding of the skin; and ii) 6 pairs of vicinal cysteines in KLK7 protein that could be binding sites for arsenic. In summary, our analysis identified non-synonymous SNPs that could be used to evaluate responsiveness of a protein target to arsenic. In particular, an epidermal expressed serine protease with crucial function in normal skin physiology was prioritized on the basis of abundance of vicinal cysteines for further research on arsenic-induced keratinocyte carcinogenesis.

Keywords: arsenic; keratinocytes; non-synonymous single nucleotide polymorphisms; skin cancer; toxicogenomics; vicinal cysteines

References

  1. Drug Metab Dispos. 2006 Jul;34(7):1237-46 - PubMed
  2. Annu Rev Biophys Biomol Struct. 2000;29:291-325 - PubMed
  3. Toxicology. 2006 Aug 15;225(2-3):225-33 - PubMed
  4. Carcinogenesis. 2007 Jul;28(7):1520-5 - PubMed
  5. Environ Health Perspect. 2002 Oct;110 Suppl 5:883-6 - PubMed
  6. Nucleic Acids Res. 2009 Jan;37(Database issue):D5-15 - PubMed
  7. Toxicol Appl Pharmacol. 2010 Jan 15;242(2):119-25 - PubMed
  8. Met Based Drugs. 2008;2008:260146 - PubMed
  9. Chem Biol Interact. 2009 May 15;179(2-3):321-8 - PubMed
  10. Biochemistry. 2009 Jan 20;48(2):424-32 - PubMed
  11. Nat Clin Pract Rheumatol. 2008 Apr;4(4):210-7 - PubMed
  12. J Invest Dermatol. 2000 Jan;114(1):56-63 - PubMed
  13. Mol Cell Biochem. 2004 Jan;255(1-2):47-55 - PubMed
  14. Toxicology. 2008 Jul 30;249(2-3):102-8 - PubMed
  15. Cancer Lett. 2007 Sep 18;255(1):95-106 - PubMed
  16. Mol Cell Biochem. 2005 Nov;279(1-2):105-12 - PubMed
  17. Trends Mol Med. 2009 Sep;15(9):430-8 - PubMed
  18. Toxicol Appl Pharmacol. 2005 Aug 1;206(1):66-72 - PubMed
  19. Environ Health. 2007 Feb 02;6:4 - PubMed
  20. Environ Health Perspect. 2005 Jun;113(6):A378-86 - PubMed
  21. Nucleic Acids Res. 2006 Jan 1;34(Database issue):D302-5 - PubMed
  22. Ann N Y Acad Sci. 2004 May;1020:101-9 - PubMed
  23. N Engl J Med. 1998 Nov 5;339(19):1341-8 - PubMed
  24. J Health Popul Nutr. 2006 Jun;24(2):228-35 - PubMed
  25. Nucleic Acids Res. 2001 Jan 1;29(1):308-11 - PubMed
  26. J Invest Dermatol. 2005 Sep;125(3):510-20 - PubMed
  27. Blood. 1997 May 1;89(9):3354-60 - PubMed
  28. Environ Health Perspect. 2006 Nov;114(11):1790-6 - PubMed
  29. J Environ Pathol Toxicol Oncol. 2009;28(3):241-52 - PubMed
  30. J Pharmacol Exp Ther. 2010 Jan;332(1):66-75 - PubMed
  31. Crit Rev Toxicol. 1995;25(5):397-462 - PubMed
  32. J Biochem Mol Toxicol. 2008 Mar-Apr;22(2):85-92 - PubMed
  33. BMC Med Genomics. 2008 Oct 09;1:48 - PubMed
  34. Annu Rev Genomics Hum Genet. 2006;7:61-80 - PubMed
  35. Mol Cell Biochem. 2007 Jul;301(1-2):123-30 - PubMed
  36. BMC Bioinformatics. 2006 Mar 22;7:166 - PubMed
  37. Toxicol Pathol. 2003 Nov-Dec;31(6):575-88 - PubMed
  38. Environ Health Perspect. 2002 Dec;110 Suppl 6:931-41 - PubMed
  39. Biochim Biophys Acta. 2007 Sep;1776(1):22-31 - PubMed
  40. J Mol Biol. 2006 Mar 10;356(5):1263-74 - PubMed
  41. J Biomed Sci. 2006 Sep;13(5):657-66 - PubMed
  42. Int J Cancer. 2005 Aug 10;116(1):20-6 - PubMed
  43. Int J Environ Res Public Health. 2006 Jun;3(2):136-40 - PubMed
  44. Arch Drug Inf. 2009 Dec;2(4):59-65 - PubMed
  45. Am J Epidemiol. 1992 Mar 1;135(5):462-76 - PubMed

Publication Types

Grant support